Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 19320560)

Published in Metab Syndr Relat Disord on August 01, 2009

Authors

Jorge N Rezzónico1, Mariana Rezzónico, Eduardo Pusiol, Fabian Pitoia, Hugo Niepomniszcze

Author Affiliations

1: Centro Privado de Endocrinología, Mendoza, Argentina.

Associated clinical trials:

Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes (METNODTHYR) | NCT04298684

Articles citing this

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol (2013) 2.80

Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care (2010) 1.04

Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res (2012) 1.02

The insulin and igf-I pathway in endocrine glands carcinogenesis. J Oncol (2012) 0.80

Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. J Clin Endocrinol Metab (2011) 0.79

Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer. J Clin Endocrinol Metab (2016) 0.76

The relationship between glucose metabolism disorders and malignant thyroid disease. Int J Clin Oncol (2012) 0.76

Frequency of Thyroid Nodules among Patients with Colonic Polyps. Gastroenterol Res Pract (2012) 0.75

Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer: A Large-Scale Case-Control Study. Medicine (Baltimore) (2016) 0.75

Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends. World J Surg Oncol (2016) 0.75

Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China. Int J Clin Exp Med (2015) 0.75

Relationship between metabolic syndrome and thyroid nodules in healthy Koreans. Korean J Intern Med (2015) 0.75

Perspectives of the AMP-activated kinase (AMPK) signalling pathway in thyroid cancer. Biosci Rep (2014) 0.75

Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2017) 0.75

The Association between Type 2 Diabetes Mellitus and Thyroid Cancer. J Diabetes Res (2017) 0.75

Articles by these authors

Regulation of prolactin, GH, and Pit-1 gene expression in anterior pituitary by Pitx2: An approach using Pitx2 mutants. Endocrinology (2002) 1.53

Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid (2008) 1.29

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metabol (2009) 1.14

Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord (2010) 0.99

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma. Expert Rev Anticancer Ther (2012) 0.99

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer (2002) 0.92

Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires) (2005) 0.88

Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Endocr Relat Cancer (2008) 0.85

Primary thyroid disorders in endogenous Cushing's syndrome. Eur J Endocrinol (2002) 0.84

Latin American thyroid society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metabol (2009) 0.82

The association of insulin resistance with subclinical thyrotoxicosis. Thyroid (2011) 0.80

Protocol for thyroid remnant ablation after recombinant TSH in thyroid carcinoma. Medicina (B Aires) (2009) 0.78

Recombinant human TSH: the Argentinean experience. Thyroid (2009) 0.78

Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma. Medicina (B Aires) (2006) 0.77

Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH? Eur J Nucl Med Mol Imaging (2004) 0.77

Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease. Medicina (B Aires) (2008) 0.77

Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease. Endocr Pract (2008) 0.77

Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer. J Thyroid Res (2012) 0.77

Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems. Arq Bras Endocrinol Metabol (2013) 0.76

Resolution of Cushing's syndrome and exacerbation of autoimmune thyroiditis. Thyroid (2011) 0.75

Thyroglossal duct cyst with papillary carcinoma. Thyroid (2004) 0.75

Thyroid cancer: does the size matter? Thyroid (2008) 0.75

Recombinant human TSH versus thyroid hormone withdrawal. J Nucl Med (2012) 0.75

A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A. BMC Med Genet (2002) 0.75

Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome. Medicina (B Aires) (2007) 0.75

Fatal outcome of a young woman with papillary thyroid carcinoma and graves' disease: possible implication of "cross-signalling" mechanism. Arq Bras Endocrinol Metabol (2008) 0.75

Lack of increase in the serum thyroid-stimulating hormone level after intramuscular administration of recombinant human thyroid-stimulating hormone doses in a morbidly obese patient. Endocr Pract (2011) 0.75

Tumour growth after recombinant human TSH. Clin Endocrinol (Oxf) (2002) 0.75

High prevalence of thyroid disorders in relatives of patients with familial papillary thyroid cancer. Medicina (B Aires) (2010) 0.75

Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer. Endocrine (2014) 0.75

High prevalence of thyroid nodules in patients with achrocordons (skin tags). Possible role of insulin-resistance. Medicina (B Aires) (2009) 0.75

Patients with familial non-medullary thyroid cancer have an outcome similar to that of patients with sporadic papillary thyroid tumors. Arq Bras Endocrinol Metabol (2011) 0.75

Iodine intake in Argentina. Thyroid (2006) 0.75

[Detection of a non-standard mutation in the ret protoncogene by site directed mutagenesis]. Medicina (B Aires) (2005) 0.75